Development of a new Immunoassay for the accurate determination of anti-infliximab antibodies in Crohn's Disease

被引：1
|
作者：
Imaeda, Hirotsugu [1 ]
Andoh, Akira [2 ]
Bamba, Shigeki [1 ]
Tsujikawa, Tomoyuki [1 ]
Fujiyama, Yoshihide [1 ]
机构：
[1] Shiga Univ Med Sci, Div Gastroenterol, Otsu, Shiga 52021, Japan
[2] Shiga Univ Med Sci, Div Mucosal Immunol, Grad Sch, Otsu, Shiga 52021, Japan
来源：
INFLAMMATORY BOWEL DISEASES | 2011年 / 17卷
关键词：
D O I：
10.1097/00054725-201112002-00128
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [1] Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease
    Imaeda, Hirotsugu
    Andoh, Akira
    Fujiyama, Yoshihide
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (02) : 136 - 143
  • [2] Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease
    Hirotsugu Imaeda
    Akira Andoh
    Yoshihide Fujiyama
    Journal of Gastroenterology, 2012, 47 : 136 - 143
  • [3] Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease
    Semmler, J. M.
    Pilch, A.
    Armbruster, F. P.
    Dignass, A.
    Kruis, W.
    Stein, J.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S41 - S41
  • [4] Infliximab and anti-infliximab antibody levels in Crohn's disease
    Hendy, Philip
    FRONTLINE GASTROENTEROLOGY, 2014, 5 (04) : 227 - 228
  • [5] A case of Crohn’s disease that developed anti-infliximab and anti-adalimumab antibodies
    Takahashi K.
    Fujimoto T.
    Shioya M.
    Nishida A.
    Bamba S.
    Inatomi O.
    Imaeda H.
    Kitoh K.
    Andoh A.
    Clinical Journal of Gastroenterology, 2015, 8 (2) : 88 - 91
  • [6] Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn’s Disease Is Determined by Their Concentration
    Helena Edlund
    Casper Steenholdt
    Mark A. Ainsworth
    Eva Goebgen
    Jørn Brynskov
    Ole Ø. Thomsen
    Wilhelm Huisinga
    Charlotte Kloft
    The AAPS Journal, 2017, 19 : 223 - 233
  • [7] Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn's Disease Is Determined by Their Concentration
    Edlund, Helena
    Steenholdt, Casper
    Ainsworth, Mark A.
    Goebgen, Eva
    Brynskov, Jorn
    Thomsen, Ole O.
    Huisinga, Wilhelm
    Kloft, Charlotte
    AAPS JOURNAL, 2017, 19 (01): : 223 - 233
  • [8] The New Immunoassay for the Accurate Determination of Antibodies to Infliximab, and Relationship Between Its Serum Level and Inflammatory Values in Crohn's Disease
    Imaeda, Hirotsugu
    Andoh, Akira
    Ban, Hiromitsu
    Bamba, Shigeki
    Sasaki, Masaya
    Tsujikawa, Tomoyuki
    Fujiyama, Yoshihide
    GASTROENTEROLOGY, 2012, 142 (05) : S349 - S349
  • [9] Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease
    Steenholdt, Casper
    Bendtzen, Klaus
    Brynskov, Jorn
    Thomsen, Ole Ostergaard
    Ainsworth, Mark Andrew
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2011, 46 (03) : 310 - 318
  • [10] Anti-infliximab antibodies in Crohn's disease patients are specific and do not cross-react with other therapeutic antibodies
    Rojas, JR
    McCabe, D
    Diamond, RH
    Wagner, C
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S251 - S251
12345